3//SEC Filing
Eclipse GP III, LLC 3
Accession 0001209191-21-007928
CIK 0001652724other
Filed
Feb 3, 7:00 PM ET
Accepted
Feb 4, 8:25 PM ET
Size
15.6 KB
Accession
0001209191-21-007928
Insider Transaction Report
Form 3
Eclipse Ventures Fund I, L.P.
10% Owner
Holdings
- (indirect: See footnote)
Series A Preferred Stock
→ Common Stock (976,852 underlying) - (indirect: See footnote)
Series B Preferred Stock
→ Common Stock (877,445 underlying) - (indirect: See footnote)
Series C Preferred Stock
→ Common Stock (185,512 underlying) Series C Preferred Stock
→ Common Stock (3,710,257 underlying)Convertible Promissory Note
Exercise: $13.60Exp: 2022-12-11→ Common Stock (473,729 underlying)
Eclipse Fund III, L.P.
10% Owner
Holdings
- (indirect: See footnote)
Series A Preferred Stock
→ Common Stock (976,852 underlying) - (indirect: See footnote)
Series B Preferred Stock
→ Common Stock (877,445 underlying) Series C Preferred Stock
→ Common Stock (3,710,257 underlying)Convertible Promissory Note
Exercise: $13.60Exp: 2022-12-11→ Common Stock (473,729 underlying)- (indirect: See footnote)
Series C Preferred Stock
→ Common Stock (185,512 underlying)
Eclipse Ventures GP I, LLC
10% Owner
Holdings
- (indirect: See footnote)
Series A Preferred Stock
→ Common Stock (976,852 underlying) - (indirect: See footnote)
Series C Preferred Stock
→ Common Stock (185,512 underlying) Convertible Promissory Note
Exercise: $13.60Exp: 2022-12-11→ Common Stock (473,729 underlying)- (indirect: See footnote)
Series B Preferred Stock
→ Common Stock (877,445 underlying) Series C Preferred Stock
→ Common Stock (3,710,257 underlying)
Eclipse GP III, LLC
10% Owner
Holdings
- (indirect: See footnote)
Series A Preferred Stock
→ Common Stock (976,852 underlying) - (indirect: See footnote)
Series B Preferred Stock
→ Common Stock (877,445 underlying) - (indirect: See footnote)
Series C Preferred Stock
→ Common Stock (185,512 underlying) Series C Preferred Stock
→ Common Stock (3,710,257 underlying)Convertible Promissory Note
Exercise: $13.60Exp: 2022-12-11→ Common Stock (473,729 underlying)
Footnotes (4)
- [F1]Each share of Series A Preferred Stock, Series B Preferred Stock, and Series C Preferred Stock (the "Preferred Stock") automatically converts on a one-for-one basis into Common Stock upon the closing of the Issuer's initial public offering (the "IPO"), for no additional consideration. The shares of Preferred Stock have no expiration date.
- [F2]The securities are held directly by Eclipse Ventures Fund I, L.P. ("Eclipse I"). Eclipse Ventures GP I, LLC ("Eclipse I GP") is the general partner of Eclipse I and may be deemed to have voting and dispositive power over the shares held by Eclipse I. Mr. Susan, a member of the Issuer's board of directors, is the sole managing member of Eclipse I GP and may be deemed to have voting and dispositive power over the shares held by Eclipse I. Eclipse I GP and Mr. Susan disclaim beneficial ownership of the shares held by Eclipse I except to the extent of their respective pecuniary interests therein, if any.
- [F3]The securities are held directly by Eclipse Fund III, L.P. ("Eclipse III"). Eclipse GP III, LLC ("Eclipse III GP") is the general partner of Eclipse III and may be deemed to have voting and dispositive power over the shares held by Eclipse III. Mr. Susan, a member of the Issuer's board of directors, is the sole managing member of Eclipse III GP and may be deemed to have voting and dispositive power over the shares held by Eclipse III. Eclipse III GP and Mr. Susan disclaim beneficial ownership of the shares held by Eclipse III except to the extent of their respective pecuniary interests therein, if any.
- [F4]The convertible promissory note will automatically convert into shares of the Issuer's Common Stock upon the closing of the IPO.
Documents
Issuer
Lucira Health, Inc.
CIK 0001652724
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001763854
Filing Metadata
- Form type
- 3
- Filed
- Feb 3, 7:00 PM ET
- Accepted
- Feb 4, 8:25 PM ET
- Size
- 15.6 KB